Seven NSCLC-associated genes (CDKN2A, RASSF1, MGMT, RARB, DAPK, WIF1 and FHIT) hypermethylation showed significant evidences in the smoking NSCLC patients compared with nonsmoking NSCLC patients. This evidence concerns the gene CDKN2A and non-small cell lung carcinoma.